The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nippon Life India Trustee Ltd
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The stock exchange has received a disclosure under Regulation 29(2) of SEBI's Substantial Acquisition of Shares & Takeovers (SAST) Regulations, 2011, filed by Nippon Life India Trustee Ltd in Suraksha Diagnostic Ltd. Regulation 29(2) disclosures are triggered when a shareholder acquires or disposes of 2% or more of the company's share capital in a single transaction or over a financial year. Nippon Life India Trustee Ltd acts on behalf of various Nippon India mutual fund schemes, making this an institutional/mutual fund disclosure rather than a promoter-related one. The exact direction of the transaction (acquisition or disposal) and the precise quantum are not indicated in the headline provided.
This signals active position-building or trimming by Nippon India Mutual Fund in Suraksha Diagnostic. Retail investors should check the detailed filing to see whether the fund is buying or selling, as it reflects institutional sentiment on the stock.